Oral Presentation Program

Oral Presentation Program

April 25 (Fri) 14:00-17:00
Room 1
14:00-15:20
15:20-15:40
15:40-17:00 / Satellite Symposium 1 : Sponsored by Pfizer Company
Updated treatment trend for invasive fungal infections in patients with hematological malignancies.
Maertens, Johan (Belgium)
Coffee Break
Satellite Symposium 2 : Sponsored by Johnson & Johnson Company
A New Era on Treating Multiple Myeloma:
Bortezomib Observational Study-China Experience
Shen, Zhi Xiang (China)
Bortezomib TreatmentTaiwan Experience
Huang, Shang-Yi (Taiwan)
Novel Agents in Induction Regimens for SCT
Huang, Xiao Jun (China)
Bortezomib-based Induction Regimen for SCT
Yoon, Sung-Soo (Korea)
April 25 (Fri) 14:00-17:00
Room 3
14:00-17:00 / APBMT business meeting
Chairman: Kodera, Yoshihisa (Japan)
April 25 (Fri) 18:00-19:30
Room 2
18:00-19:30 / Opening Ceremony & Welcome Dinner
Chairmen: Chen, Po-Min (Taiwan) Asano, Shigetaka(Japan)
Young, Ji-Hsiung (Taiwan) Chiou, Tzeon-Jye (Taiwan)
April 26 (Sat) 08:15-12:00
Room 1
08:15-08:45
08:45-09:15
09:15-09:30
09:30-09:45
09:45-10:00 / Chairperson:
KeynoteLecture:
Chairpersons:
Invited Speaker:
Chairn) / O-1-1
O-1-2
O-1-3
O-1-4
O-1-5 / Workshop “CML”
Shih, Lee-Yung (Taiwan)
The maintenance of CML treatment.Le Coutre, Philipp (Germany)
Kim, Dong-Wook (Korea) Naoe, Tomoki (Japan)
Molecular monitoring of BCR-ABL transcripts with identification of BCR-ABL kinase domain mutations in imatinib-treated patients with chronic myeloid leukemia: CGMH experience
Shih, Lee-Yung (Taiwan)
Haploidentical blood and bone marrow transplantation in advanced chronic myeloid leukemia: a single-center report of 29 patients.
Zhao, Yanli (China)
Hematological, cytogenetic, and molecular response afterimatinib treatment in newly diagnosed chronic phase chronic myeloid leukemia patient.
Hsu, Szu-Chun (Taiwan)
Clinical features ofpatients with PDGFR-beta fusion gene-positive chronic myeloproliferative disorders: a preliminary study in Taiwan.
Yu, Yuan-Bin (Taiwan)
10:00-10:15 / Coffee Break
10:15-10:45
10:45-11:15
11:15-11:30
11:30-11:45
11:45-12:00 / Chairperson:
Keynote Lecture:
Chairpersons:
Invited Speaker: / O-1-6
O-1-7
O-1-8
O-1-9
O-1-10 / Workshop “Multiple Myeloma”
Kim, Dong-Jip (Korea)
Transplantation of Multiple Myeloma: The role of novel agents.
Lonial,Sagar (USA)
Chao, Tsu-Yi (Taiwan) Lee, Jong-Wook (Korea)
Asia-Pacific DAZZLE study for newly-diagnosed myeloma.
Teoh,Gerrard (Singapore)
Multiple myeloma in Taiwan-treatment paradigm shift.
Huang, Shang-Yi (Taiwan)
Sequential VAD and VTD induction followed by high-dose therapy with autologous stem cells transplantation and maintenancetreatment with velcade for newly diagnosed multiple myeloma: Interim result of a phase II trial.
Yoon, Sung-Soo (Korea)
Bortezomib regulates the survival and cell migration through down- regulation of focal adhesion kinase (FAK) expression in myeloma and hepatocellular carcinoma (HCC).
Ko, Bor-Sheng (Taiwan)
12:00-13:00 / Satellite Symposium 3 : Sponsored by Schering-Plough Company
Advances in the Management of Fungal Infections: Applying Evidence-Based Data to Clinical Practice
A New Option in Antifungal Therapy: Posaconazole
Slavin, Monica
Management of Patients at High risk of Invasive Fungal Infections: The Role of Posaconazole
Couriel,Daniel R
13:00-15:00 / General Assembly of the TaiwanSociety of Blood and Marrow Transplantation, 2008
015:00-15:10
115:10-15:20
115:20-15:30
115:30-15:40
115:40-15:50
115:50-16:00
116:00-16:10
116:10-16:20
116:20-16:30 / Chairpersons:
Invited Speaker:
Invited Speaker:
Invited Speaker:
Invited Speaker:
Invited Speaker:
Invited Speaker:
Invited Speaker:
Invited Speaker:
Invited Speaker: / O-1-11
O-1-12
O-1-13
O-1-14
O-1-15
O-1-16
O-1-17
O-1-18
O-1-19 / Workshop “Registration and Follow-up System for Asian BMT Patients”
Aljurf, Mahmoud (Saudi Arabia) Huang, Xiaojun (China)
Tran, Van Binh (Vietnam) Liang, Der-Cherng (Taiwan)
Hematopoietic stem cell transplantation in the eastern mediterranean.
Murphy, Andrea (Saudi Arabia)
Stem cell transplantation in Iran.
Ghavamzadeh, Ardeshir (Iran)
Haematopoietic stem cell transplantation in aplastic anemia in Asia- Pacific region.
Shamsi,Tahir Sultan (Pakistan)
Hematopoietic stem cell transplantation in thalassemia:not a single entity.
Hongeng, Suradej (Thailand)
Current status of hematopoietic stem cell transplantation in Vietnam.
Tran, Van Binh (Vietnam)
Syngeneic blood and marrow transplantation: a report of Chinese Society of Blood and Marrow transplantation (CSBMT).
Lu, Dao-Pei(China)
Transplant activity survey of APBMT 2007: updated.
Yoshimi, Ayami (Japan)
Autologous hematopoietic stem cell transplantation in patients with autoimmune disease- 61 cases report.
Ouyang,Jian (China)
Treatment results for children with acute myeloid leukemia in Taiwan.
Liang, Der-Cherng (Taiwan)
18:00-21:00 / Gala Dinner
April 26 (Sat) 08:10-12:00
Room 2
08:10-08:40
08:40-08:50
08:50-09:00
09:00-09:10
09:10-09:20
09:20-09:30
09:30-09:40
09:40-09:50 / Chairperson:
Keynote Lecture:
Chairpersons:
Cha
)
Invited Speaker: / O-1-20
O-1-21
O-1-22
O-1-23
O-1-24
O-1-25
O-1-26
O-1-27 / Workshop “Infection & Other Supportive Care”
Huang, He (China)
Bleeding as a complication of bone marrow transplant.
Gabriel,Don A (USA)
Jootar, Saengsuree (Thailand) Liang, Raymond (Hong Kong) Hwang, Wei-Shou (Taiwan)
Favorable response to low dose steroid treatment in Japanese patients with chronic graft-versus-host disease.
Atsuta, Yoshiko (Japan)
High dose of corticosteroid therapy during the first 100 days increase adenovirus infection following allogeneic hematopoietic stem cell transplantation.
Miyamura, Koichi (Japan)
Post-transplantation hemosiderosis in hematopoietic stem cell transplant recipients and pilot treatment with oral deferasirox.
Liang, Raymond (Hong Kong)
Poor outcome in post-transplant lymphoproliferative disorder (PTLD) with pulmonary involvement following allogeneic hematopoietic stem cell transplantation(ALLO-HSCT): 13 years’ experience in a single institute.
Hou, Hsin-An (Taiwan)
Antifungal prophylaxis and treatment with Itraconazole after allogeneic hematopoietic stem cell transplantation.
Huang, He (China)
Cytomegalovirus infections in sero-positive population after hematopoietic stem cell transplantation.
Tan, Tran-Der (Taiwan)
Lamivudine prophylaxis prevents reactivation of hepatitis B in lymphoma patients receiving rituximab treatment.
Lin, Tung-Liang (Taiwan)
09:50-10:00 / Coffee Break
10:00-10:30
10:30-10:45
10:45-11:05
11:05-11:20
11:20-11:30
11:30-11:40
11:40-11:50
11:50-12:00 / Chairperson:
Keynote Lecture:
Chairpersons:
Invited Speaker: / O-1-28
O-1-29
O-1-30
O-1-31
O-1-32
O-1-33
O-1-34 / Workshop “Stem Cell Biology & Umbilical Cord Blood Transplantation”
Asano, Shigetaka (Japan)
Stem cell biology.
Ehninger,Gerhard (Germany)
Mobilization strategies for transplantation.
Ehninger,
Taiwan)e (China) an)ion.
Gerhard (Germany)
Ouyang, Jian(China) Lin, Hai Peng (Malaysia) Chiu, Chang-Fang(Taiwan)
Changes in TF-1 cell properties by co-culturing with MS5 cells.
Funayama, Keiji (Japan)
Direct intra-cardiac injection of autologous marrow stem cells to treat chronic myocardial ischemia: The Newcastle, Australia experience 2001-2007.
Rowlings, Philip (Australia)
Is a boost dose of granulocyte-stimulating factor necessary for healthy PBSC donors undergoing secondary aphresis? An institute’s experience.
Yang, Shang-Hsien (Taiwan)
Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: influence of disease, mobilization method, age and sex.
Chen, Xinghua (China)
Reduced-intensity unrelated cord blood transplantation in adult hematological diseases.
Taniguchi, Shuichi (Japan)
Cord blood for allogeneic stem cell transplantation for MDS patients in Japan.
Takahashi, Satoshi (Japan)
12:00-13:00 / Satellite Symposium 4 : Sponsored by Roche Company
Current Management of Follicular Lymphomas.
Hiddemann,Wolfgang (Germany)
April 26 (Sat) 13:00-17:00
Room 2
0
113:00-13:30
113:30-13:45
113:45-13:55
113:55-14:05
114:05-14:15
114:15-14:25
114:25-14:35
114:35-14:45 / Chairperson:
Keynote Lecture:
Chairpersons:
Invited Speaker: / O-1-35
O-1-36
O-1-37
O-1-38
O-1-39
O-1-40
O-1-41
O-1-42 / Workshop “Lymphoma”
Lee, Kun Soo (Korea)
Current Management of Follicular Lymphomas.
Hiddemann,Wolfgang (Germany)
Saikia, Tapan K (India) Wang, Jianmin (China) Lin, Sheng-Fung (Taiwan)
Use of rituximab in peri-transplant setting of relapsed/refractory classical Hodgkin’s lymphoma.
Saikia, Tapan K (India)
Autologous hematopoietic stem cell transplantation for patients with relapsed or refractory lymphoid malignancies: long-tern outcome from a single institution.
Liu, Yi-Chang (Taiwan)
BOMES chemotherapy (BCNU, vincristin, methotrexate, etoposide and methylprednisolone): an effective salvage regimen for patients with relapsed and/or refractory non-Hodgkin’s lymphoma.
Lin, Po-Han (Taiwan)
Rituximab-containing chemotherapy in first-line maintenance versus on demand in follicular non-Hodgkin’s lymphoma.
Chang, Ming-Chih (Taiwan)
Improved outcome of diffuse large B cell lymphoma after the additionof rituximab: a retrospective analysis post the era of WHO classification in Tri-serviceGeneralHospital.
Ho, Ching-Liang (Taiwan)
Chemotherapy with addition of rituximab improves the outcome of patients with diffuse large B-cell lymphoma: a retrospective, single center study.
Yang, Meng-Ju (Taiwan)
Non-gastric mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 12 patients by MackayMemorialHospital.
Cheng, Hung-I (Taiwan)
14:45-15:00 / Coffee Break
15:00-15:20
15:20-15:40
15:40-16:00
16:00-16:20
16:20-16:40
16:40-17:00 / Chairperson: / O-1-43
O-1-44
O-1-45
O-1-46
O-1-47
O-1-48 / Workshop “HSCT Nursing Care”
Kim, Kwang-Sung (Korea) Farzana, Tasheem (Pakistan)
Shiu-Yu Katie C.Lee (Taiwan)
Nursing care: The backbone of successful Haematopoietic stem cell program.
Farzana, Tasheem (Pakistan)
Complicated long term care issues after stem cell transplantation.
Kim, Kwang-Sung (Korea)
Patient care during infusion of hematopoietic progenitor cells.
Yang, Mei-Hua (Taiwan)
The distress symptoms post hematopoietic stem-cell transplantation among discharged patients.
Chang, Wen-Hua (Taiwan)
Thedecision-making of cancer patients with hematopoietic stem cell Transplantation.
Kao, Wei-Ching (Taiwan)
An exploratory study of stressors and coping strategies among cancer ward nurses in a medical centre in central Taiwan.
Yeh, Tzu-Pei(Taiwan)
April 27 (Sun) 08:15-12:00
Room 1
08:15-08:45
08:45-09:00
09:00-09:10
09:10-09:20
09:20-09:30
09:30-09:40
09:40-09:50 / Chairperson:
Keynote Lecture:
Chairpersons:
Invited Speaker:
Chairn) / O-2-1
O-2-2
O-2-3
O-2-4
O-2-5
O-2-6
O-2-7 / Workshop “Transplantation Immunity & Unrelated Transplantation”
Tojo, Arinobu (Japan)
Allogeneic T-cell responses for the treatment of hematological malignancies.
Falkenburg,J.H. Frederik (Netherlands)
Liu, Kaiyan(China) Takahashi, Satoshi(Japan) Chen, Yao-Chang(Taiwan)
Outcome of hematopoietic stem cell transplantation for congenital immunodeficiency disorders- a single centre experience.
Chan, Lee-Lee(Malaysia)
Chronic GVHD associated gene scanning among Japanese stem cell transplantation cases.
Onizuka, Makoto (Japan)
Graft-versus-leukemia effect following related or unrelated donor hematopoietic stem cell transplantation for acute lymphoblastic leukemia in first complete remission.
Huang, He (China)
Lung transplantation after stem cell transplant: a case series.
Potter,Victoria (Australia)
Adoptive cellular therapy for refractory cytomegalovirus infection/ disease following allogeneic blood and marrow transplantation.
Wu, Tong(China)
Management of EBV reactivation following allogeneic blood and marrow transplantation with viral-specific lymphocytes.
Wu, Tong (China)
09:50-10:15 / Coffee Break
10:15-10:45
10:45-11:15
11:15-11:25
11:25-11:35
11:35-11:45
11:45-11:55 / Chairperson:
Keynote Lecture:
Chairpersons:
Invited Speaker: / O-2-8
O-2-9
O-2-10
O-2-11
O-2-12
O-2-13 / Workshop “HLA Typing & Others”
Yang, Kuo-Liang (Taiwan)
HLA and KIR: polymorphism, interaction, and clinical implication.
Gao, Xiaojiang (USA)
Hwang, Tai-Ju (Korea) Miyamura, Koichi(Japan)
Tzeng, Cheng-Hwai(Taiwan)
Determination of HLA-A, -B and -DRB1 haplotypes based on allelic homozygosity data in selected bone marrow donors of the Tzu Chi Taiwan Marrow Donor Registry.
Yang, Kuo-Liang (Taiwan)
Clinical study on HLA-mismatched sibling allogeneic peripheral blood stem cell trsnsplantation.
Yuan, Hai-Long (China)
Comparative analysis of multiple factors of hemorrhagic cystitis after HLA-mismatched and HLA-matched peripheral blood hematopoietic stem cell transplantation.
Yuan, Hai-Long (China)
Role of FDG-PET/CT in the diagnosis of extramedullary relapse of leukemia after allogeneic stem cell transplantation.
Yoshihara, Satoshi (Japan)
Novel compound band 3 mutations associated hereditary spherocytosis and renal tubular acidosis.
Chang, Yu-Hsiang (Taiwan)
12:00-13:00 / Satellite Symposium 5 : Sponsored by Bayer Company
New Concept: Radioimmunotherapy in Bone Marrow Transplantation
Gisselbrecht, Christian
15:00-17:00 / General Assembly of the Hematology Society of Taiwan, 2008
April 27 (Sun) 08:15-12:00
Room 2
08:15-08:45
08:45-09:15
09:15-09:25
09:25-09:35
09:35-09:45
09:45-09:55
09:55-10:05 / Chairperson:
Keynote Lecture:
Chairpersons:
Invited Speaker: / O-2-14
O-2-15
O-2-16
O-2-17
O-2-18
O-2-19
O-2-20 / Workshop “Preparative Regimens & Acute Leukemia”
Kodera, Yoshihisa (Japan)
Ablative and nonmyeloablative preparative regimens for allogeneic stem cell transplantation: role of antithymocyte globulin.
Champlin,Richard (USA)
Okamoto, Shinichiro(Japan) Shen, Zhixiang(China) Tang, Jih-Luh(Taiwan)
Current status in the treatment and monitoring of Ph(+) ALL patients.
Grigg,Andrew Paul (Australia)
Effect of myeloablative stem cell transplantation on patients with remission state of adult T cell leukemia/lymphoma (ATL): a single center experience in 35 patients.
Takemoto, Shigeki (Japan)
Comparison of radiation versus non-radiation containing conditioning regimens in stem cell transplantation (SCT) for pediatric leukemia.
Han, Dong Kyun (Korea)
The addition of etoposide or fludarabine to the BuCy conditioning regimen is a risk factor for late-onset hemorrhagic cystitis after allogeneic HSCT.
Huang,Tai-Chung (Taiwan)
Sequential RQ-PCR monitoring of PML-RAR transcripts in patients with acute promyelocytic leukemia.
Kuo, Ming-Chung (Taiwan)
High frequency of Runx1 mutations in de novo acute myeloid leukemia with partial tandem duplication of MLL.
Su, Yung-Cheng (Taiwan)
10:05-10:15 / Coffee Break
10:15-10:40
10:40-10:55
10:55-11:10
11:10-11:20
11:20-11:30
11:30-11:40
11:40-11:50 / Chairperson:
KeynoteLecture:
Chairpersons:
Invited Speaker
Invited Speaker / O-2-21
O-2-22
O-2-23
O-2-24
O-2-25
O-2-26
O-2-27 / Workshop “Thalassemia & Coagulopathy”
Issaragrisil, Surapol (Thailand)
Thalassemia: quest for better management.
Lin, Kai-Hsin (Taiwan)
Harada, Mine (Japan) Chaudhary, Qamar Un Nisa (Pakistan) Lin, Kai-Hsin (Taiwan)
Hematopoietic stem cell transplantation for thalassemia.
Issaragrisil, Surapol (Thailand)
Cure in ß-thalassaemia major with bone marrow transplantation – single centre experience from Pakistan.
Chaudhary, Qamar Un Nisa (Pakistan)
High prevalence of low bone mass in patients with transfusion dependent thalassemia major.
Lu, Meng-Yao (Taiwan)
Clinical experience of EXJADE in a tertiary care hospital in Taiwan.
Chang, Hsiu-Hao (Taiwan)
A novel Asp68His missense mutation associated with Factor V deficiency: molecular characterization by expression of recombinant protein.
Shen, Ming-Ching (Taiwan)
Intron one inversion of patients with hemophilia A in Taiwan: an single institute analysis.
Wu, Yi-Ying (Taiwan)
12:00-13:00 / Satellite Symposium 6 : Sponsored by Bristol-Myers Squibb(Twiaan)LTD
Emerging data update on use of dasatinib.
Grigg,Andrew Paul (Australia)
April 27 (Sun) 13:00-14:30
Room 2
13:00-13:30
13:30-13:40
13:40-13:50
13:50-14:00
14:00-14:10
14:10-14:20
14:20-14:30 / Chairperson:
Keynote lecture
Chairpersons: / O-2-28
O-2-29
O-2-30
O-2-31
O-2-32
O-2-33
O-2-34 / Workshop “MDS,MPD & Others”
Lu, Dao-Pei (China)
Recent advances in myelodysplastic syndromes.
Tien, Hwei-Fang (Taiwan)
Ma, Jun (China) Park, Hee Sook (Korea) Tien, Hwei-Fang (Taiwan)
Data from the registry of patients with myelodysplastic syndrome of a Romania single hospital center. Analysis of the group under 50 years old. Gologan, Radu (Romania)
Use of anti-platelet antibody as a predictor of patients with immune thrombocytopenic purpura response to steroids.
Chang, Yuan-Hsin (Taiwan)
Emodin as a potent inhibitor restrains JAK2V617F activity.
Chen, Gon-Shen (Taiwan)
The expression of aurora kinases in hematological malignancies.
Chen, Ya-Ping (Taiwan)
Molecular analysis of JAK2 in hematological disorders.
Su, Nai-Wen(Taiwan)
SOCS-1 expression in essential thrombocythemia.
Hsiao, Hui-Hua (Taiwan)

1